BMRN vs TECH · P/E 40, rev $2.85B vs P/E 65, rev $1.22B
Biomarin Pharmaceutical Inc (BMRN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BMRN and TECH stock pages for the full models.
Not investment advice.